10x Genomics Inc - Ordinary Shares - Class A
TXG
Market Cap$3.06B
Close$
$42.06
51.3% upside
Current Fair Value
51.3% upsideUndervalued by 51.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.06 Billion |
|---|---|
| Enterprise Value | $2.67 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.18 |
| Beta | 2.09 |
| Outstanding Shares | 105,642,301 |
| Avg 30 Day Volume | 1,514,214 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -11.99 |
|---|---|
| PEG | -6.5 |
| Price to Sales | 5.56 |
| Price to Book Ratio | 3.97 |
| Enterprise Value to Revenue | 4.31 |
| Enterprise Value to EBIT | -13.06 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About 10x Genomics Inc
CEO: Serge Saxonov